Screener
Ocular Therapeutix OCUL Total Revenue
Total Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Revenue: | ||
| Product revenue, net | $10,785 | $10,634 |
| Collaboration revenue | — | 64 |
| Total revenue, net | 10,785 | 10,698 |
| Costs and operating expenses: | ||
| Cost of product revenue | 1,329 | 1,262 |
| Research and development | 66,213 | 42,857 |
| Selling and marketing | 16,577 | 14,148 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's total revenue?
- Ocular Therapeutix (OCUL) reported total revenue of $10.79M in Q1 2026.
- How has Ocular Therapeutix's total revenue changed year-over-year?
- Ocular Therapeutix's total revenue increased by 0.8% year-over-year, from $10.7M to $10.79M.
- What is the long-term trend for Ocular Therapeutix's total revenue?
- Over 4 years (2021 to 2025), Ocular Therapeutix's total revenue has grown at a 4.5% compound annual growth rate (CAGR), from $43.52M to $51.95M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Ocular Therapeutix's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude